by Caltron Clays | Feb 19, 2026 | Pharmaceutical Materials
Introduction: The global joint health supplement market is undergoing a structural transformation. Nutraceutical manufacturers are no longer satisfied with single-ingredient formulations that target only one pathway of cartilage support. Instead, the industry is...
by Caltron Clays | Feb 14, 2026 | Pharmaceutical Materials
Introduction: Calcium deficiency remains one of the most persistent global micronutrient challenges despite decades of supplementation efforts. Across Asia, Europe, North America, and emerging economies, inadequate calcium intake continues to affect bone density,...
by Caltron Clays | Feb 10, 2026 | Pharmaceutical Materials
Introduction: Calcium remains one of the most researched and widely consumed minerals in human nutrition, yet calcium deficiency continues to affect populations across age groups worldwide. From inadequate bone development in children to accelerated bone loss in...
by Caltron Clays | Feb 5, 2026 | Pharmaceutical Materials
Introduction: The Global Shift Toward Natural, High-Absorption Calcium Sources The global pharmaceutical and nutraceutical landscape is witnessing a decisive shift in mineral nutrition strategy. Calcium supplementation, once dominated by commodity-grade mined calcium...
by Caltron Clays | Jan 27, 2026 | Pharmaceutical Materials
Introduction – Why Marine Minerals Are the Future of Pharmaceutical – Grade Nutrition The global pharmaceutical and nutraceutical industries are entering a new phase one driven by clean-label formulations, higher bioavailability, and sustainable sourcing. As...
Recent Comments